Search

Your search keyword '"Lingjærde, Ole Christian"' showing total 479 results

Search Constraints

Start Over You searched for: Author "Lingjærde, Ole Christian" Remove constraint Author: "Lingjærde, Ole Christian"
479 results on '"Lingjærde, Ole Christian"'

Search Results

1. Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma

3. Deep learning for automated scoring of immunohistochemically stained tumour tissue sections – Validation across tumour types based on patient outcomes

4. Transcriptomic subtyping of malignant peripheral nerve sheath tumours highlights immune signatures, genomic profiles, patient survival and therapeutic targets

5. Germline HOXB13 mutations p.G84E and p.R217C do not confer an increased breast cancer risk

6. A Systemic Protein Deviation Score Linked to PD-1+ CD8+ T Cell Expansion That Predicts Overall Survival in Diffuse Large B Cell Lymphoma

7. Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: A randomized phase 2b trial

8. Comprehensive multi-omics analysis of breast cancer reveals distinct long-term prognostic subtypes.

9. Mutational dynamics and immune evasion in diffuse large B-cell lymphoma explored in a relapse-enriched patient series

10. Ipilimumab and nivolumab combined with anthracycline-based chemotherapy in metastatic hormone receptor-positive breast cancer: a randomized phase 2b trial

12. REPLY TO PARK ET AL.

16. Implementing precision cancer medicine in the public health services of Norway: the diagnostic infrastructure and a cost estimate

17. Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

18. Gene expression and copy number profiling of follicular lymphoma biopsies from patients treated with first-line rituximab without chemotherapy.

19. Table S1 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

20. Abstract 5627: Spatial protein profiling by cyclic immunofluorescence to interpret and improve bulk tumor-based predictor of response to chemotherapy with bevacizumab in neoadjuvant breast cancer treatment

21. Data from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

22. Abstract 2170: Pre-treatment protein landscape in HER2-negative breast cancer treated with carboplatin in a neoadjuvant chemotherapy setting

23. Table S5-S9 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

24. Table S10A and S10B from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

25. Figures FS1-FS15 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

26. Supplementary Methods SM1 from Proteome Analysis of Pancreatic Tumors Implicates Extracellular Matrix in Patient Outcome

27. Supplementary Figure S3. The figure shows CNA profile of three IPMN samples. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

28. Supplementary Figure S5. Frequency plot of the CNAs of periampullary adenocarcinomas based on site of origin. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

29. Supplementary Table S1: Frequencies of gains and losses for selected genes in both OUH and TCGA cohorts. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

30. Supplementary Figure S1. Heatmap shows the cytobands amplified and deleted in OUH and TCGA cohort. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

31. Supplementary Tables from The Longitudinal Transcriptional Response to Neoadjuvant Chemotherapy with and without Bevacizumab in Breast Cancer

32. Supplementary table S1 from T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling

33. Supplementary methods and references, Supplementary Figures 1-9 from T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling

34. Supplementary Figure S2. CNA profile of the two xenografts cell lines and their original tumors. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

35. Data from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

36. Supplementary Table S3: Table shows the pathway deregulated in OUH and TCGA cohort. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

37. Supplementary Figure S4. Correlation between genome instability index (GII) and ploidy. from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

38. Supplementary figures 1-9 from T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized by Reversible Suppression of T-cell Receptor Signaling

39. Supplementary file: Legends of supplementary material from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

40. Supplementary Table S2: Table shows the correlation score (r) between allele frequency and gene expression from The Genomic Landscape of Pancreatic and Periampullary Adenocarcinoma

42. Breast cancer quantitative proteome and proteogenomic landscape

43. Author Correction: Pan-cancer analysis of homozygous deletions in primary tumours uncovers rare tumour suppressors

44. Time series analysis of neoadjuvant chemotherapy and bevacizumab-treated breast carcinomas reveals a systemic shift in genomic aberrations

45. A deep learning system accurately classifies primary and metastatic cancers using passenger mutation patterns

46. Combined burden and functional impact tests for cancer driver discovery using DriverPower

47. Integrative pathway enrichment analysis of multivariate omics data

48. Pathway and network analysis of more than 2500 whole cancer genomes

49. Divergent mutational processes distinguish hypoxic and normoxic tumours

50. Genomic footprints of activated telomere maintenance mechanisms in cancer

Catalog

Books, media, physical & digital resources